Tom D Wilsdon
Overview
Explore the profile of Tom D Wilsdon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Murray-Brown W, Wilsdon T, Weedon H, Proudman S, Sukumaran S, Klebe S, et al.
J Immunother Cancer
. 2020 Jun;
8(1).
PMID: 32571993
Background: Immune checkpoint inhibitors (ICIs) are associated with rheumatic and musculoskeletal immune-related adverse events (irAEs) in 5%-20% of patients. Currently, patients refractory to corticosteroids and conventional disease-modifying antirheumatic drugs (cDMARD)...
2.
Wilsdon T, Whittle S, Thynne T, Mangoni A
Cochrane Database Syst Rev
. 2019 Jan;
1:CD012722.
PMID: 30656673
Background: Psoriatic arthritis is an inflammatory disease associated with joint damage, impaired function, pain, and reduced quality of life. Methotrexate is a disease-modifying anti-rheumatic drug (DMARD) commonly prescribed to alleviate...
3.
4.
Wilsdon T, Hendrix I, Thynne T, Mangoni A
Drugs Aging
. 2017 Feb;
34(4):265-287.
PMID: 28220380
Background: The use of proton pump inhibitors (PPIs) in older adults is high, often inappropriate, and may cause harm. Deprescribing is defined as the reduction, withdrawal, or discontinuation of inappropriate...